Cargando…
Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy
Cyanidin-3-O-glucoside (C3G) is a kind of anthocyanin which shows strong anti-inflammation, anti-tumor and anti-oxidant properties. This paper was designed to explore the potential effects of C3G on diabetic retinopathy (DR). C57BL/6 mice were administrated with streptozotocin (STZ) or vehicle contr...
Autores principales: | Zhao, Fangling, Gao, Xiang, Ge, XiaoJuan, Cui, Jiawen, Liu, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810139/ https://www.ncbi.nlm.nih.gov/pubmed/34699316 http://dx.doi.org/10.1080/21655979.2021.1996512 |
Ejemplares similares
-
Effect of intravitreal and intraperitoneal cyanidin-3-glucoside injection in oxygen-induced retinopathy mouse model
por: Ercan, Zeynep E, et al.
Publicado: (2019) -
Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach
por: Li, Weizhen, et al.
Publicado: (2018) -
Chemical Hemisynthesis of Sulfated Cyanidin-3-O-Glucoside and Cyanidin Metabolites
por: Straßmann, Sarah, et al.
Publicado: (2021) -
Association of the Pattern of Retinal Capillary Non-Perfusion and Vascular Leakage with Retinal Neovascularization in Proliferative Diabetic Retinopathy
por: Jung, Eric E., et al.
Publicado: (2021) -
Anti‐inflammatory activity of cyanidin‐3‐O‐glucoside and cyanidin‐3‐O‐glucoside liposomes in THP‐1 macrophages
por: Hao, Xuefang, et al.
Publicado: (2021)